AR012181A1 - Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. - Google Patents

Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.

Info

Publication number
AR012181A1
AR012181A1 ARP980101380A ARP980101380A AR012181A1 AR 012181 A1 AR012181 A1 AR 012181A1 AR P980101380 A ARP980101380 A AR P980101380A AR P980101380 A ARP980101380 A AR P980101380A AR 012181 A1 AR012181 A1 AR 012181A1
Authority
AR
Argentina
Prior art keywords
methyl
hydrogen
substituted
formula
pirimidine
Prior art date
Application number
ARP980101380A
Other languages
English (en)
Spanish (es)
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of AR012181A1 publication Critical patent/AR012181A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP980101380A 1997-03-27 1998-03-26 Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. AR012181A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970010863 1997-03-27
KR19970010862 1997-03-27

Publications (1)

Publication Number Publication Date
AR012181A1 true AR012181A1 (es) 2000-09-27

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101380A AR012181A1 (es) 1997-03-27 1998-03-26 Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.

Country Status (21)

Country Link
US (1) US6352993B1 (OSRAM)
EP (1) EP1015444B1 (OSRAM)
JP (1) JP3176379B2 (OSRAM)
KR (1) KR100278857B1 (OSRAM)
CN (1) CN1118464C (OSRAM)
AR (1) AR012181A1 (OSRAM)
AT (1) ATE241613T1 (OSRAM)
AU (1) AU720385B2 (OSRAM)
BR (1) BR9808070A (OSRAM)
CA (1) CA2284795C (OSRAM)
DE (1) DE69815126T2 (OSRAM)
DK (1) DK1015444T3 (OSRAM)
ES (1) ES2200324T3 (OSRAM)
HU (1) HUP0000851A3 (OSRAM)
IN (1) IN188411B (OSRAM)
PT (1) PT1015444E (OSRAM)
RU (1) RU2203894C2 (OSRAM)
TR (1) TR199902383T2 (OSRAM)
TW (1) TW542831B (OSRAM)
UY (1) UY24938A1 (OSRAM)
WO (1) WO1998043968A1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
WO2005009980A1 (en) * 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
CA2541989C (en) * 2003-10-24 2013-10-01 Exelixis, Inc. P70s6 kinase modulators and method of use
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
WO2007042571A1 (en) * 2005-10-14 2007-04-19 Neurosearch A/S Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びtv受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
PL2308877T3 (pl) 2008-08-05 2014-07-31 Daiichi Sankyo Co Ltd Pochodne imidazopirydyn-2-onu
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CA2817165A1 (en) 2010-11-15 2012-05-24 Patrick Chaltin Novel antiviral compounds
US9890138B2 (en) 2011-02-25 2018-02-13 Yuhan Corporation Diaminopyrimidine derivatives and processes for the preparation thereof
AU2013221286B2 (en) * 2012-02-17 2017-06-15 Abbvie Inc. Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (RSV)
WO2013181136A1 (en) 2012-05-29 2013-12-05 Momentive Performance Materials Gmbh Preparation of isocyanato silanes
SG11201503982XA (en) 2012-11-21 2015-06-29 Ptc Therapeutics Inc Substituted reverse pyrimidine bmi-1 inhibitors
US10035801B2 (en) 2013-03-13 2018-07-31 Genentech, Inc. Pyrazolo compounds and uses thereof
NZ718055A (en) 2013-08-30 2020-01-31 Ptc Therapeutics Inc Substituted pyrimidine bmi-1 inhibitors
US10125144B2 (en) * 2013-10-07 2018-11-13 Kadmon Corporation, Llc Rho kinase inhibitors
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
EP3209299A4 (en) * 2014-10-22 2018-04-04 The Board of Regents of The University of Texas System Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
PL3397622T3 (pl) * 2016-01-04 2022-07-04 ObsEva S.A. Jednoczesne podawanie alfa-aminoestrowej pochodnej hydroksypropylotiazolidynokarboksyamidu i środka tokolitycznego
JP7107962B2 (ja) * 2017-04-05 2022-07-27 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 2-アミノ-5-オキシアルキル-ピリミジン誘導体および望ましくない植物成長を防除するためのその使用
WO2020055544A2 (en) 2018-08-17 2020-03-19 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
EP0388838B1 (de) 1989-03-22 1996-01-10 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
JPH05507290A (ja) 1990-11-06 1993-10-21 フアイザー・インコーポレイテツド 抗腫瘍活性を強化するためのキナゾリン誘導体
DE9290039U1 (de) * 1991-04-17 1993-12-09 Pfizer Inc., New York, N.Y. Pyrimidinderivate zur Verbesserung der Anti-Tumor-Aktivität
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE69432019T2 (de) * 1993-08-12 2003-11-27 Astrazeneca Ab, Soedertaelje Amidin-derivate mit stickstoffoxid-synthease-aktivität
ATE163647T1 (de) 1993-08-26 1998-03-15 Ono Pharmaceutical Co 4-aminopyrimidin derivate
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
AU688087B2 (en) * 1994-08-13 1998-03-05 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
ATE206117T1 (de) * 1996-05-04 2001-10-15 Yuhan Corp Verfahren zur herstellung von pyrimidin-derivaten

Also Published As

Publication number Publication date
EP1015444B1 (en) 2003-05-28
AU720385B2 (en) 2000-06-01
WO1998043968A1 (en) 1998-10-08
DE69815126T2 (de) 2004-04-08
HUP0000851A1 (hu) 2001-04-28
KR19980080789A (ko) 1998-11-25
TR199902383T2 (xx) 2000-06-21
CN1251586A (zh) 2000-04-26
ES2200324T3 (es) 2004-03-01
PT1015444E (pt) 2003-10-31
JP2000513014A (ja) 2000-10-03
UY24938A1 (es) 2001-01-31
ATE241613T1 (de) 2003-06-15
DK1015444T3 (da) 2003-08-18
IN188411B (OSRAM) 2002-09-21
CA2284795A1 (en) 1998-10-08
KR100278857B1 (ko) 2001-01-15
JP3176379B2 (ja) 2001-06-18
TW542831B (en) 2003-07-21
CN1118464C (zh) 2003-08-20
HK1026418A1 (en) 2000-12-15
DE69815126D1 (de) 2003-07-03
RU2203894C2 (ru) 2003-05-10
HUP0000851A3 (en) 2002-04-29
US6352993B1 (en) 2002-03-05
AU6523998A (en) 1998-10-22
BR9808070A (pt) 2000-03-08
CA2284795C (en) 2004-01-20
EP1015444A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
AR012181A1 (es) Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.
AR030959A1 (es) Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen
AR038883A1 (es) Compuestos que modulan la actividad de ppar, composicion farmaceutica que los contiene y un metodo para prepararlos
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
PE72899A1 (es) Derivados sulfonamida
PE20020566A1 (es) DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
PE20010482A1 (es) Derivados de 3-ureido-pirazol y procedimiento para su preparacion
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
AR019427A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
TN2010000026A1 (fr) Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
DK0704448T3 (da) Nye imidazolidiner substitueret med en heterocyklisk forbindelse, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
BR9102322A (pt) Derivados de morfolino-ureia,processo para sua preparacao,composicoes inseticidas e acaricidas,processo para o combate de insetos e acaros,utilizacao e processo para a preparacao de composicoes
AR005338A1 (es) Derivados acetidinalquilicos de heterociclos con nitrogeno n-sustituido o sales farmaceuticamente aceptables de los mismos, un procedimiento paraprepararlos, composiciones farmaceuticas que los comprenden, uso de dichos derivados, sales y composiciones, y compuestos utilizables como intermedios
CO4770955A1 (es) Acidos 4-amino-2-heterobiciclo [3.1.0] hexano -4,6- dicarboxilicos
ES2032384T3 (es) Procedimiento para preparar derivados de carboxamidas.
PT99028A (pt) Processo para a preparacao de compostos azabiciclicos
DK425382A (da) Fremgangsmaade til fremstilling af amider
AR024222A1 (es) Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
YU13899A (sh) Pirolidinil i pirolinil etilaminska jedinjenja kao kapa agonisti
CO5590934A2 (es) Procedimiento de preparacion de derivados de equinocandina

Legal Events

Date Code Title Description
FB Suspension of granting procedure